Agios Pharmaceuticals
AGIO
#5284
Rank
C$2.18 B
Marketcap
C$36.79
Share price
-0.85%
Change (1 day)
-6.09%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -C$0.66 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are C$54.02 Million. a decrease over its 2024 earnings that were of -C$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.65 Billion10.9%
2024 -C$0.59 Billion8.75%
2023 -C$0.54 Billion0.63%
2022 -C$0.54 Billion2.81%
2021 -C$0.52 Billion10.58%
2020 -C$0.47 Billion-18.41%
2019 -C$0.58 Billion15.72%
2018 -C$0.5 Billion12.99%
2017 -C$0.44 Billion59.61%
2016 -C$0.28 Billion69.32%
2015 -C$0.17 Billion119.28%
2014 -C$73.83 Million39.22%
2013 -C$53.03 Million69.1%
2012 -C$31.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$13.89 B-2,258.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.09 B-5,549.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.49 B-2,195.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-C$0.19 Billion-70.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.28 B-299.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.65 B-202.19%๐Ÿ‡บ๐Ÿ‡ธ USA